208 related articles for article (PubMed ID: 35011619)
1. TRAIL Triggers CRAC-Dependent Calcium Influx and Apoptosis through the Recruitment of Autophagy Proteins to Death-Inducing Signaling Complex.
Airiau K; Vacher P; Micheau O; Prouzet-Mauleon V; Kroemer G; Moosavi MA; Djavaheri-Mergny M
Cells; 2021 Dec; 11(1):. PubMed ID: 35011619
[TBL] [Abstract][Full Text] [Related]
2. Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells.
Mazurek N; Byrd JC; Sun Y; Hafley M; Ramirez K; Burks J; Bresalier RS
Cell Death Differ; 2012 Mar; 19(3):523-33. PubMed ID: 21941373
[TBL] [Abstract][Full Text] [Related]
3. DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.
Bellail AC; Tse MC; Song JH; Phuphanich S; Olson JJ; Sun SY; Hao C
J Cell Mol Med; 2010 Jun; 14(6A):1303-17. PubMed ID: 19432816
[TBL] [Abstract][Full Text] [Related]
4. TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells.
Uno K; Inukai T; Kayagaki N; Goi K; Sato H; Nemoto A; Takahashi K; Kagami K; Yamaguchi N; Yagita H; Okumura K; Koyama-Okazaki T; Suzuki T; Sugita K; Nakazawa S
Blood; 2003 May; 101(9):3658-67. PubMed ID: 12506034
[TBL] [Abstract][Full Text] [Related]
5. Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer.
Pennarun B; Meijer A; de Vries EG; Kleibeuker JH; Kruyt F; de Jong S
Biochim Biophys Acta; 2010 Apr; 1805(2):123-40. PubMed ID: 19961901
[TBL] [Abstract][Full Text] [Related]
6. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation.
Rosato RR; Almenara JA; Coe S; Grant S
Cancer Res; 2007 Oct; 67(19):9490-500. PubMed ID: 17909059
[TBL] [Abstract][Full Text] [Related]
7. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A
Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681
[TBL] [Abstract][Full Text] [Related]
8. Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
Kohlhaas SL; Craxton A; Sun XM; Pinkoski MJ; Cohen GM
J Biol Chem; 2007 Apr; 282(17):12831-41. PubMed ID: 17327223
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level.
Morizot A; Mérino D; Lalaoui N; Jacquemin G; Granci V; Iessi E; Lanneau D; Bouyer F; Solary E; Chauffert B; Saas P; Garrido C; Micheau O
Cell Death Differ; 2011 Apr; 18(4):700-11. PubMed ID: 21072058
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation.
Chen L; Meng Y; Sun Q; Zhang Z; Guo X; Sheng X; Tai G; Cheng H; Zhou Y
Cell Death Dis; 2016 Aug; 7(8):e2334. PubMed ID: 27512955
[TBL] [Abstract][Full Text] [Related]
11. Targeting CAMKK2 and SOC Channels as a Novel Therapeutic Approach for Sensitizing Acute Promyelocytic Leukemia Cells to All-Trans Retinoic Acid.
Merhi F; Alvarez-Valadez K; Trepiana J; Lescoat C; Groppi A; Dupuy JW; Soubeyran P; Kroemer G; Vacher P; Djavaheri-Mergny M
Cells; 2021 Nov; 10(12):. PubMed ID: 34943872
[TBL] [Abstract][Full Text] [Related]
12. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways.
Seki N; Toh U; Sayers TJ; Fujii T; Miyagi M; Akagi Y; Kusukawa J; Kage M; Shirouzu K; Yamana H
Mol Cancer Ther; 2010 Jun; 9(6):1842-51. PubMed ID: 20515944
[TBL] [Abstract][Full Text] [Related]
14. A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells.
Park KJ; Lee SH; Kim TI; Lee HW; Lee CH; Kim EH; Jang JY; Choi KS; Kwon MH; Kim YS
Cancer Res; 2007 Aug; 67(15):7327-34. PubMed ID: 17671202
[TBL] [Abstract][Full Text] [Related]
15. PIM kinases mediate resistance of glioblastoma cells to TRAIL by a p62/SQSTM1-dependent mechanism.
Serrano-Saenz S; Palacios C; Delgado-Bellido D; López-Jiménez L; Garcia-Diaz A; Soto-Serrano Y; Casal JI; Bartolomé RA; Fernández-Luna JL; López-Rivas A; Oliver FJ
Cell Death Dis; 2019 Jan; 10(2):51. PubMed ID: 30718520
[TBL] [Abstract][Full Text] [Related]
16. Reversal of the Apoptotic Resistance of Non-Small-Cell Lung Carcinoma towards TRAIL by Natural Product Toosendanin.
Li X; You M; Liu YJ; Ma L; Jin PP; Zhou R; Zhang ZX; Hua B; Ji XJ; Cheng XY; Yin F; Chen Y; Yin W
Sci Rep; 2017 Feb; 7():42748. PubMed ID: 28209994
[TBL] [Abstract][Full Text] [Related]
17. Cetuximab enhances TRAIL-induced gastric cancer cell apoptosis by promoting DISC formation in lipid rafts.
Xu L; Hu X; Qu X; Hou K; Zheng H; Liu Y
Biochem Biophys Res Commun; 2013 Sep; 439(2):285-90. PubMed ID: 23973713
[TBL] [Abstract][Full Text] [Related]
18. Akt-phosphorylated mitogen-activated kinase-activating death domain protein (MADD) inhibits TRAIL-induced apoptosis by blocking Fas-associated death domain (FADD) association with death receptor 4.
Li P; Jayarama S; Ganesh L; Mordi D; Carr R; Kanteti P; Hay N; Prabhakar BS
J Biol Chem; 2010 Jul; 285(29):22713-22. PubMed ID: 20484047
[TBL] [Abstract][Full Text] [Related]
19. Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts.
Psahoulia FH; Drosopoulos KG; Doubravska L; Andera L; Pintzas A
Mol Cancer Ther; 2007 Sep; 6(9):2591-9. PubMed ID: 17876056
[TBL] [Abstract][Full Text] [Related]
20. Peroxiredoxin 6 interferes with TRAIL-induced death-inducing signaling complex formation by binding to death effector domain caspase.
Choi H; Chang JW; Jung YK
Cell Death Differ; 2011 Mar; 18(3):405-14. PubMed ID: 20829884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]